Schmid P, Lipatov O, Im SA, Goncalves A, et al. Impact of pembrolizumab versus chemotherapy on health-related quality of life in patients with metastatic triple-negative breast cancer: results from the phase 3 randomised KEYNOTE-119 study. Eur J Cancer 2023;195:113393.
PMID: 37976633